Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04871516 · ClinicalTrials.gov registry record · NA

Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer

A NA study of Anatomic Stage II Breast Cancer AJCC v8 and Anatomic Stage I Breast Cancer AJCC v8, sponsored by Rutgers, The State University of New Jersey.

Active
Registry status
NA
Development phase
103
Enrollment target
11
Study locations

NCT04871516 is a NA study of Anatomic Stage II Breast Cancer AJCC v8 and Anatomic Stage I Breast Cancer AJCC v8 that is active but no longer recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 103 participants, below the 355-participant average among 73 other Anatomic Stage II Breast Cancer AJCC v8 trials with a reported enrollment target (71% lower). The trial reports 11 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04871516, a NA study of Anatomic Stage II Breast Cancer AJCC v8 and Anatomic Stage I Breast Cancer AJCC v8, is active but no longer recruiting, sponsored by Rutgers, The State University of New Jersey.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
103 participants
Enrollment target
11
Study locations

Study Summary

This phase II trial investigates the safety of delivering a part (boost) of radiation treatment before breast surgery in treating patients with breast cancer that has not spread to other places in the body (non-metastatic). Radiation therapy uses high energy photons/electrons to kill tumor cells and shrink tumors. Delivering a boost radiation treatment before surgery when doctors can still visualize the tumor on imaging may help to better target the tumor and decrease the volume of normal irradiated tissue. By so doing, doctors may achieve better cosmetic outcomes and possibly better tumor control.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration
  • RADIATION Radiation Boost
  • RADIATION Whole Breast Irradiation
  • PROCEDURE Therapeutic Surgical Procedure

Study Locations (11)

New Jersey

  • Clara Maass Medical Center - Belleville
  • RWJBarnabas Health-Trinitas Hospital and Comprehensive Care - Elizabeth
  • The Cancer Institute of New Jersey Hamilton - Hamilton
  • RWJBarnabas Health Jersey City Medical Center - Jersey City
  • RWJBarnabas Health - Monmouth Medical Center Southern Campus - Lakewood
  • Cooperman Barnabas Medical Center (Saint Barnabas Medical Center) - Livingston
  • Rutgers Cancer Institute of New Jersey - New Brunswick
  • Rutgers New Jersey Medical School - Newark
  • RWJBarnabas Health - Newark Beth Israel Medical Center - Newark
  • Robert Wood Johnson University Hospital Somerset - Somerville
  • RWJBarnabas Health - Community Medical Center - Toms River

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2021-05-18
Est. Completion 2028-01-31
Phase NA

What the Registry Record Tells You About NCT04871516

The ClinicalTrials.gov registry entry for NCT04871516 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 355-participant average among 73 other Anatomic Stage II Breast Cancer AJCC v8 trials with a reported enrollment target (71% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Anatomic Stage II Breast Cancer AJCC v8 appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.

NCT04871516 reports 11 study locations spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT04871516 about?

NCT04871516 is a clinical study titled "Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer". This phase II trial investigates the safety of delivering a part (boost) of radiation treatment before breast surgery in treating patients with breast cancer that has not spread to other places in the body (non-metastatic). Radiation therapy uses high energy photons/electrons to kill tumor cells and...

What is the current status of trial NCT04871516?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 103 participants. The study started on 2021-05-18. Estimated completion is 2028-01-31.

What conditions does trial NCT04871516 study?

This clinical trial studies the following conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Invasive Breast Carcinoma, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8.

What interventions are being tested in trial NCT04871516?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Radiation Boost (RADIATION), Whole Breast Irradiation (RADIATION), Therapeutic Surgical Procedure (PROCEDURE).

Who is sponsoring clinical trial NCT04871516?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04871516 being conducted?

This trial has 11 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anatomic Stage II Breast Cancer AJCC v8

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.